Retour
20
Fourchette du Jour
320,22 €
331,27 €
Fourchette 52 Semaines
265,59 €
377,54 €
Volume
948 549
Moyenne 50J / 200J
354,06 €
/
324,91 €
Clôture Précédente
326,91 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (625 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 40,1 | 14,0 |
| P/B | 41,4 | 2,4 |
| ROE % | 144,3 | 11,4 |
| Net Margin % | 0,5 | 10,1 |
| Rev Growth 5Y % | 10,7 | 7,0 |
| D/E | 7,1 | 0,5 |
Points Clés
Revenue grew 10,70% annually over 5 years — strong growth
ROE of 144,31% indicates high profitability
Debt/Equity of 7,13 — high leverage
Generating 3,21B in free cash flow
P/E of 40,13 — premium valuation
Cash machine — converts 206,36% of earnings into free cash flow
Croissance
Revenue Growth (5Y)
10,70%
Revenue (1Y)9,31%
Earnings (1Y)2,99%
FCF Growth (3Y)-3,63%
Qualité
Return on Equity
144,31%
ROIC22,32%
Net Margin0,48%
Op. Margin1,14%
Sécurité
Debt / Equity
7,13
Current Ratio0,90
Interest Coverage8,69
Valorisation
P/E Ratio
40,13
P/B Ratio41,36
EV/EBITDA18,84
Dividend Yield0,01%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 9,31% | Revenue Growth (3Y) | 10,71% |
| Earnings Growth (1Y) | 2,99% | Earnings Growth (3Y) | -5,63% |
| Revenue Growth (5Y) | 10,70% | Earnings Growth (5Y) | 0,23% |
| Profitability | |||
| Revenue (TTM) | 321,33B | Net Income (TTM) | 1,55B |
| ROE | 144,31% | ROA | 2,03% |
| Gross Margin | 3,16% | Operating Margin | 1,14% |
| Net Margin | 0,48% | Free Cash Flow (TTM) | 3,21B |
| ROIC | 22,32% | FCF Growth (3Y) | -3,63% |
| Safety | |||
| Debt / Equity | 7,13 | Current Ratio | 0,90 |
| Interest Coverage | 8,69 | Dividend Yield | 0,01% |
| Valuation | |||
| P/E Ratio | 40,13 | P/B Ratio | 41,36 |
| P/S Ratio | 0,19 | PEG Ratio | 7,05 |
| EV/EBITDA | 18,84 | Dividend Yield | 0,01% |
| Market Cap | 62,37B | Enterprise Value | 68,72B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 321,33B | 293,96B | 262,17B | 238,59B | 213,99B |
| Net Income | 1,55B | 1,51B | 1,75B | 1,70B | 1,54B |
| EPS (Diluted) | 7,96 | 7,53 | 8,53 | 8,04 | 7,39 |
| Gross Profit | 10,14B | 8,70B | 7,76B | 7,60B | 6,27B |
| Operating Income | 3,65B | 3,04B | 2,45B | 2,75B | 2,68B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 76,59B | 67,10B | 62,56B | 56,56B | 57,34B |
| Total Liabilities | 74,84B | 66,31B | 61,89B | 56,49B | 56,75B |
| Shareholders' Equity | 1,51B | 645,94M | 522,00M | -211,56M | 223,35M |
| Total Debt | 10,75B | 6,65B | 6,82B | 7,59B | 8,75B |
| Cash & Equivalents | 4,39B | 3,23B | 2,69B | 3,53B | 2,55B |
| Current Assets | 52,24B | 47,72B | 42,80B | 39,59B | 38,80B |
| Current Liabilities | 57,82B | 54,28B | 48,83B | 43,48B | 41,36B |
Scores de Stratégies
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
#445 of 612
Activité Récente
Entré
Price/Sales Ratio Focus (Ken Fisher)
Mar 24, 2026